Read Our Research Studies
1. Elkholy M, Maaly A, Farghaly M, Mahrokhian S, Tsai L, Hanna I, Vaidya A, Sacks B, Moussa M. Effect of collection timing on selectivity index in unstimulated adrenal venous sampling: discovery and validation. Hypertens Res. 2026 Mar 6. doi: 10.1038/s41440-026-02558-z. [Epub ahead of print] PubMed [citation] PMID: 41792246.
2. Moussa M, Hamam O, Maaly A, Elkholy M, Farghaly M, Abiola G, Faintuch S, Sacks B, Vaidya A, Ahmed M, Sarwar A. The Aldosteronoma Resolution Score as a Predictive Metric for Outcomes after Radiofrequency Ablation for Primary Aldosteronism. J Vasc Interv Radiol. 2025 Nov;36(11):1705-1713. doi: 10.1016/j.jvir.2025.07.011. Epub 2025 Jul 18. PubMed [citation] PMID: 40685123.
3. Parisien-La Salle S, Heydarpour M, Tsai CH, Brown JM, Newman AJ, Mahrokhian S, Hanna I, Honzel B, Tsai LC, Waikar S, Inoue K, Zennaro MC, Auchus R, Turcu AF, Williams JS, Sacks B, Moussa M, Vaidya A. The Evolution of Primary Aldosteronism and the Role of Norrin. medRxiv. 2025 Jun 6. pii: 2025.06.05.25329066. doi: 10.1101/2025.06.05.25329066. PubMed [citation] PMID: 40502598, PMCID: PMC12154992.
4. Vaidya A, Morlote M, Moussa M, Barletta J, Nehs M. Targeting a Hormonal Cause of Hypertension. N Engl J Med. 2025 Jan 23;392(4):e14. doi: 10.1056/NEJMimc2401927. No abstract available. PubMed [citation] PMID: 39842014.
5. Faintuch S, Sacks BA. Thyroid Nodule Ablation: Ever-Expanding Indications. Radiol Imaging Cancer. 2025 Jan;7(1):e240423. doi: 10.1148/rycan.240423. No abstract available. PMID: 39750114.
6. Eldeiry LS, Faintuch S, Sacks BA. Successful Radiofrequency Ablation of an Intrathyroidal Parathyroid Adenoma After Failed Parathyroidectomy. AACE Clin Case Rep. 2024 Aug 30;10(6):253-256. doi: 10.1016/j.aace.2024.08.009. eCollection 2024 Nov-Dec. PMID: 39734504.
7. Baughman C, Mottalib A, Moussa M, Zemany L, Wagner AA, Graham K, Cluett JL. Second Time’s a Charm: When to Reconsider Secondary Hypertension Evaluations. Hypertension. 2023 Dec;80(12):2501-2505. doi: 10.1161/HYPERTENSIONAHA.123.21730. Epub 2023 Oct 13. PMID: 37830201.
8. Parksook WW, Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism. Am J Hypertens. 2022 Jun 16;35(6):561-571. doi: 10.1093/ajh/hpab189. PubMed [citation] PMID: 34883509, PMCID: PMC9890245.
9. Raje P, Broekhuis JM, Sacks BA, James BC. Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing’s Syndrome. J Surg Res. 2021 Dec;268:660-666. doi: 10.1016/j.jss.2021.08.006. Epub 2021 Sep 1. PubMed [citation] PMID: 34481219.
10. Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies. Hypertension. 2021 Jul;78(1):94-103. doi: 10.1161/HYPERTENSIONAHA.121.17248. Epub 2021 May 17. Review. PubMed [citation] PMID: 33993726, PMCID: PMC8192472.
11. Sacks BA, Sacks AC, Faintuch S. Radiofrequency Ablation Treatment for Aldosterone-Producing Adenomas. Curr Opin Endocrinol Diabetes Obes. 2017 Jun;24(3):169-173.
12. Sarwar A, Brook OR, Vaidya A, Sacks AC, Sacks BA, Goldberg SN, Ahmed M, Faintuch S. Clinical Outcomes Following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma: Comparison with Adrenalectomy. J Vasc Interv Radiol. 2016 Jul;27(7):961-7. doi: 10.1016/j.jvir.2016.03.042. Epub 2016 May 27.
13. Mendiratta-Lala M, Brennan DD, Brook OR, Faintuch S, Mowschenson PM, Sheiman RG, Goldberg SN. Efficacy of Radiofrequency Ablation in the Treatment of Small Functional Adrenal Neoplasms. Radiology. 2011 Jan;258(1):308-16.
